Pseudohypoparathyroidism Type 1a
6 clinical trials · Condition
◉ Watch Pseudohypoparathyroidism Type 1a
| Record | Firm | Date |
|---|---|---|
| Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old (NCT04551170) | Vanderbilt University Medical Center | 2020-07-13 |
| Theophylline for Treatment of Pseudohypoparathyroidism (NCT04240821) | Jaclyn Tamaroff | 2020-05-22 |
| Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy) (NCT02463409) | Vanderbilt University Medical Center | 2015-06-01 |
| Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a (NCT01398774) | Children's Hospital of Philadelphia | 2011-06-01 |
| Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments (NCT00209235) | Connecticut Children's Medical Center | 2003-01-01 |
Track Pseudohypoparathyroidism Type 1a automatically
Every clearance here is in the API, with alerts when new ones post.